Roger Pomerantz - Sep 30, 2022 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Role
Director
Signature
/s/ Roger Pomerantz
Stock symbol
INDP
Transactions as of
Sep 30, 2022
Transactions value $
$0
Form type
4
Date filed
10/3/2022, 04:30 PM
Previous filing
Aug 29, 2022
Next filing
Nov 29, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INDP Stock Option (right to buy) Award $0 +81K $0.00 81K Sep 30, 2022 Common Stock 81K $2.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable as to one-half of the total shares on September 30, 2023 and thereafter the remaining shares vest and become exercisable on September 30, 2024.